These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 10378768)
1. An enhanced active efflux of CPT-11 and SN-38 in cisplatin-resistant human KB carcinoma cells. Chen ZS; Sumizawa T; Furukawa T; Ono K; Tani A; Komatsu M; Akiyama S Cancer Lett; 1999 Apr; 138(1-2):13-22. PubMed ID: 10378768 [TBL] [Abstract][Full Text] [Related]
2. ATP-Dependent efflux of CPT-11 and SN-38 by the multidrug resistance protein (MRP) and its inhibition by PAK-104P. Chen ZS; Furukawa T; Sumizawa T; Ono K; Ueda K; Seto K; Akiyama SI Mol Pharmacol; 1999 May; 55(5):921-8. PubMed ID: 10220571 [TBL] [Abstract][Full Text] [Related]
3. Characterization of the ATP-dependent LTC4 transporter in cisplatin-resistant human KB cells. Chuman Y; Chen ZS; Sumizawa T; Furukawa T; Haraguchi M; Takebayashi Y; Niwa K; Yamada K; Aikou T; Akiyama S Biochem Biophys Res Commun; 1996 Sep; 226(1):158-65. PubMed ID: 8806607 [TBL] [Abstract][Full Text] [Related]
4. Active efflux of CPT-11 and its metabolites in human KB-derived cell lines. Chu XY; Suzuki H; Ueda K; Kato Y; Akiyama S; Sugiyama Y J Pharmacol Exp Ther; 1999 Feb; 288(2):735-41. PubMed ID: 9918583 [TBL] [Abstract][Full Text] [Related]
5. An active efflux system for heavy metals in cisplatin-resistant human KB carcinoma cells. Chen ZS; Mutoh M; Sumizawa T; Furukawa T; Haraguchi M; Tani A; Saijo N; Kondo T; Akiyama S Exp Cell Res; 1998 May; 240(2):312-20. PubMed ID: 9597004 [TBL] [Abstract][Full Text] [Related]
6. Differences in substrate specificity among glutathione conjugates (GS-X) pump family members: comparison between multidrug resistance-associated protein and a novel transporter expressed on a cisplatin-resistant cell line (KCP-4). Ueda K; Suzuki H; Akiyama S; Sugiyama Y Jpn J Cancer Res; 1999 Apr; 90(4):439-47. PubMed ID: 10363583 [TBL] [Abstract][Full Text] [Related]
7. Effect of P-glycoprotein modulator, cyclosporin A, on the gastrointestinal excretion of irinotecan and its metabolite SN-38 in rats. Arimori K; Kuroki N; Hidaka M; Iwakiri T; Yamsaki K; Okumura M; Ono H; Takamura N; Kikuchi M; Nakano M Pharm Res; 2003 Jun; 20(6):910-7. PubMed ID: 12817897 [TBL] [Abstract][Full Text] [Related]
8. Adenosine triphosphate-dependent transport of leukotriene C4 by membrane vesicles prepared from cisplatin-resistant human epidermoid carcinoma tumor cells. Fujii R; Mutoh M; Sumizawa T; Chen ZS; Yoshimura A; Akiyama S J Natl Cancer Inst; 1994 Dec; 86(23):1781-4. PubMed ID: 7966417 [TBL] [Abstract][Full Text] [Related]
9. Sensitivity to anticancer agents and resistance mechanisms in clear cell carcinoma of the ovary. Itamochi H; Kigawa J; Sultana H; Iba T; Akeshima R; Kamazawa S; Kanamori Y; Terakawa N Jpn J Cancer Res; 2002 Jun; 93(6):723-8. PubMed ID: 12079522 [TBL] [Abstract][Full Text] [Related]
10. Drug-induced down-regulation of topoisomerase I in human epidermoid cancer cells resistant to saintopin and camptothecins. Taniguchi K; Kohno K; Kawanami K; Wada M; Kanematsu T; Kuwano M Cancer Res; 1996 May; 56(10):2348-54. PubMed ID: 8625310 [TBL] [Abstract][Full Text] [Related]
11. CPT-11 sensitivity in relation to the expression of P170-glycoprotein and multidrug resistance-associated protein. Jansen WJ; Hulscher TM; van Ark-Otte J; Giaccone G; Pinedo HM; Boven E Br J Cancer; 1998; 77(3):359-65. PubMed ID: 9472629 [TBL] [Abstract][Full Text] [Related]
12. Novel camptothecin analogues that circumvent ABCG2-associated drug resistance in human tumor cells. Yoshikawa M; Ikegami Y; Hayasaka S; Ishii K; Ito A; Sano K; Suzuki T; Togawa T; Yoshida H; Soda H; Oka M; Kohno S; Sawada S; Ishikawa T; Tanabe S Int J Cancer; 2004 Jul; 110(6):921-7. PubMed ID: 15170677 [TBL] [Abstract][Full Text] [Related]
13. Multiplicity of biliary excretion mechanisms for the camptothecin derivative irinotecan (CPT-11), its metabolite SN-38, and its glucuronide: role of canalicular multispecific organic anion transporter and P-glycoprotein. Sugiyama Y; Kato Y; Chu X Cancer Chemother Pharmacol; 1998; 42 Suppl():S44-9. PubMed ID: 9750028 [TBL] [Abstract][Full Text] [Related]
14. Growth inhibitory effect of a new camptothecin analog, DX-8951f, on various drug-resistant sublines including BCRP-mediated camptothecin derivative-resistant variants derived from the human lung cancer cell line PC-6. Ishii M; Iwahana M; Mitsui I; Minami M; Imagawa S; Tohgo A; Ejima A Anticancer Drugs; 2000 Jun; 11(5):353-62. PubMed ID: 10912951 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of topoisomerase I catalytic activity as determinant of drug response in human cancer cell lines. Voigt W; Vanhoefer U; Yin MB; Minderman H; Schmoll HJ; Rustum YM Anticancer Res; 1997; 17(5A):3707-11. PubMed ID: 9413228 [TBL] [Abstract][Full Text] [Related]
16. Human multidrug resistance associated protein 4 confers resistance to camptothecins. Tian Q; Zhang J; Tan TM; Chan E; Duan W; Chan SY; Boelsterli UA; Ho PC; Yang H; Bian JS; Huang M; Zhu YZ; Xiong W; Li X; Zhou S Pharm Res; 2005 Nov; 22(11):1837-53. PubMed ID: 16132345 [TBL] [Abstract][Full Text] [Related]
17. Factors involved in the cisplatin resistance of KCP‑4 human epidermoid carcinoma cells. Oiso S; Takayama Y; Nakazaki R; Matsunaga N; Motooka C; Yamamura A; Ikeda R; Nakamura K; Takeda Y; Kariyazono H Oncol Rep; 2014 Feb; 31(2):719-26. PubMed ID: 24317338 [TBL] [Abstract][Full Text] [Related]
18. Paclitaxel and SN-38 overcome cisplatin resistance of ovarian cancer cell lines by down-regulating the influx and efflux system of cisplatin. Komuro Y; Udagawa Y; Susumu N; Aoki D; Kubota T; Nozawa S Jpn J Cancer Res; 2001 Nov; 92(11):1242-50. PubMed ID: 11714450 [TBL] [Abstract][Full Text] [Related]
19. DX-8951f, a water-soluble camptothecin analog, exhibits potent antitumor activity against a human lung cancer cell line and its SN-38-resistant variant. Joto N; Ishii M; Minami M; Kuga H; Mitsui I; Tohgo A Int J Cancer; 1997 Aug; 72(4):680-6. PubMed ID: 9259410 [TBL] [Abstract][Full Text] [Related]
20. Intestinal transport of irinotecan in Caco-2 cells and MDCK II cells overexpressing efflux transporters Pgp, cMOAT, and MRP1. Luo FR; Paranjpe PV; Guo A; Rubin E; Sinko P Drug Metab Dispos; 2002 Jul; 30(7):763-70. PubMed ID: 12065434 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]